Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
accelerated, announced, approximately, Assisted, conception, deemed, delivery, dramatic, earned, experiencing, facilitating, factor, hope, ICSI, injection, intracytoplasmic, IVF, LOCAL, locally, machinery, male, men, past, pivotal, population, pregnancy, prevalence, proportion, prospective, reclassified, reportedly, sperm, strategy, strong, threshold, unblinded, undergoing
Removed:
Europe, noted
Filing tables
Filing exhibits
Related press release
FEMY similar filings
Filing view
External links
Exhibit 32.1
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the Quarterly Report of Femasys Inc., a Delaware Corporation, (the “Company”) on Form 10-Q for the quarter ended September 30, 2022, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), the undersigned certify the following pursuant to Section 18, U.S.C. 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002:
1. The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
2. The information contained in the report fairly presents, in all material respects, the financial condition and results of operations of the Company.
FEMASYS INC. | ||
Date: November 10, 2022 | By: | /s/ Kathy Lee-Sepsick |
Kathy Lee-Sepsick | ||
Chief Executive Officer and President | ||
(principal executive officer) |